Select Biotechnology Portfolio (FBIOX) is an MF managed by Fidelity. Its largest position is AbbVie Inc. (ABBV), representing 13.22% of fund assets.
Select Biotechnology Portfolio Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- FBIOX
- Type:
- MF
- Manager:
- Fidelity
- Total Assets:
- —
- Report Date:
- Feb 28, 2026
- Filing Date:
- Apr 24, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
AbbVie Inc.
|
13.22% | $707,712,178.56 | 3,049,432 |
|
-
Krystal Biotech, Inc.
|
9.30% | $497,949,724.08 | 1,806,522 |
|
-
GILEAD SCIENCES, INC.
|
8.77% | $469,185,350.40 | 3,149,952 |
|
-
AMGEN INC
|
8.34% | $446,209,716.16 | 1,149,551 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
3.09% | $165,355,704.36 | 496,683 |
|
-
FIDELITY REVERE STREET TRUST
|
2.55% | $136,230,210.30 | 136,216,589 |
|
-
Praxis Precision Medicines, Inc.
|
2.46% | $131,500,875.00 | 390,500 |
|
-
Ascendis Pharma A/S
|
2.44% | $130,339,933.50 | 558,201 |
|
-
INSMED Inc
|
2.26% | $121,121,712.33 | 811,101 |
|
-
APPLIED MATERIALS INC /DE
|
2.17% | $116,347,579.17 | 390,274 |
|
-
ARGENX SE
|
2.14% | $114,534,900.48 | 149,344 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
1.48% | $79,195,677.72 | 101,316 |
|
-
Moderna, Inc.
|
1.43% | $76,740,578.53 | 1,432,529 |
|
-
Scholar Rock Holding Corp
|
1.37% | $73,065,377.23 | 1,650,449 |
|
-
Natera, Inc.
|
1.29% | $68,971,917.28 | 331,532 |
|
-
Cogent Biosciences, Inc.
|
1.23% | $65,710,656.90 | 1,691,394 |
|
-
CENTESSA PHARMACEUTICALS PLC
|
1.10% | $58,756,088.84 | 2,187,494 |
|
-
BIOGEN INC.
|
1.07% | $57,437,621.70 | 299,435 |
|
-
Roivant Sciences Ltd.
|
1.07% | $57,090,487.86 | 1,972,719 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
1.05% | $56,092,107.00 | 112,900 |
|
-
BridgeBio Pharma, Inc.
|
0.88% | $47,021,569.92 | 707,304 |
|
-
Protagonist Therapeutics, Inc
|
0.87% | $46,658,133.04 | 506,713 |
|
-
Immunome Inc.
|
0.87% | $46,598,175.04 | 2,131,664 |
|
-
TERNS PHARMACEUTICALS INC
|
0.85% | $45,455,314.32 | 1,079,186 |
|
-
Revolution Medicines, Inc.
|
0.84% | $44,763,519.44 | 438,772 |
|
-
Kymera Therapeutics, Inc.
|
0.79% | $42,243,985.35 | 462,441 |
|
-
IONIS PHARMACEUTICALS INC
|
0.72% | $38,657,993.55 | 476,377 |
|
-
ArriVent BioPharma, Inc.
|
0.72% | $38,589,668.91 | 1,680,003 |
|
-
CRINETICS PHARMACEUTICALS INC
|
0.71% | $38,086,178.10 | 926,671 |
|
-
Abivax S.A.
|
0.68% | $36,578,048.00 | 301,600 |
|
-
Structure Therapeutics Inc.
|
0.66% | $35,548,305.24 | 564,438 |
|
-
Disc Medicine, Inc.
|
0.66% | $35,453,431.88 | 532,174 |
|
-
APPLIED MATERIALS INC /DE
|
0.65% | $34,847,192.70 | 184,660 |
|
-
APPLIED MATERIALS INC /DE
|
0.63% | $33,892,955.59 | 589,130 |
|
-
CYTOKINETICS INC
|
0.59% | $31,307,548.50 | 503,175 |
|
-
Candel Therapeutics, Inc.
|
0.58% | $31,037,742.75 | 5,911,951 |
|
-
Viridian Therapeutics, Inc.\DE
|
0.55% | $29,415,373.52 | 1,001,204 |
|
-
Vaxcyte, Inc.
|
0.54% | $29,045,891.70 | 470,455 |
|
-
Stoke Therapeutics, Inc.
|
0.54% | $28,858,347.54 | 792,594 |
|
-
NUVALENT INC-A
|
0.52% | $27,873,028.05 | 273,399 |
|
-
APOGEE THERAPEUTICS INC
|
0.51% | $27,492,990.00 | 392,757 |
|
-
Trevi Therapeutics, Inc.
|
0.51% | $27,278,741.20 | 2,288,485 |
|
-
Annexon, Inc.
|
0.50% | $26,508,137.60 | 4,733,596 |
|
-
ARROWHEAD PHARMACEUTICALS, INC.
|
0.48% | $25,901,346.06 | 409,378 |
|
-
Dianthus Therapeutics, Inc. /DE/
|
0.45% | $23,854,111.42 | 432,218 |
|
-
Vor Biopharma Inc.
|
0.44% | $23,717,770.00 | 1,536,125 |
|
-
Edgewise Therapeutics, Inc.
|
0.44% | $23,649,597.00 | 776,925 |
|
-
UNITED THERAPEUTICS Corp
|
0.42% | $22,470,412.70 | 44,593 |
|
-
Intellia Therapeutics, Inc.
|
0.41% | $22,155,938.74 | 1,607,833 |
|
-
Travere Therapeutics, Inc.
|
0.40% | $21,459,017.97 | 720,343 |
Advertisement (320x50)